Research Article
Intravenous Iron Therapy in Patients with Iron Deficiency Anemia: Dosing Considerations
Table 6
Hb >12 g/dL and end of treatment (Day 56) from clinical Study 7 (ITT population).
| ||||||||||||||||||||
Hb = hemoglobin; ITT = intent-to-treat. Data on file, Luitpold Pharmaceuticals, Inc. |